Danish Obesity Startup Ousia Gets Funds From US Investor Omega
This article is for subscribers only.
The US venture capital firm Omega Funds is backing a Danish biotech startup, betting it can deliver a new type of obesity treatment.
The Boston-based investor made a “substantial” investment in Ousia Pharma, it said Tuesday without disclosing the amount. The company’s research could tackle some of the limitations of existing obesity medicines, Omega Funds said.